1. MODELLING THE CLONAL EVOLUTION OF BURKITT LYMPHOMA USING PATIENT-DERIVED XENOGRAFTS. (October 2022) Authors: Chang, S.; Blair, H.; Bell, N.; Nakjang, S.; Steel, C.; Iliasova, A.; Zaka, M.; Singh, M.; Vogiatzi, F.; Frith, K.; Bashton, M.; Loeffen, J.; Schewe, D.; Heidenreich, O.; Vormoor, J.; Rand, V.; Bacon, C.; Bomken, S. Journal: Leukemia research Issue: Volume 121(2022)Supplement Page Start: S51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Monitoring the dynamics of clonal tumor evolution in vivo using secreted luciferases. (July 2016) Authors: Charles, J.P.; Fuchs, J.; Hefter, M.; Vischedyk, J.B.; Kleint, M.; Vogiatzi, F.; Nist, A.; Timofeev, O.; Wanzel, M.; Stiewe, T. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mutant p53 promotes tumor progression by the endoplasmic reticulum UDPase ENTPD5. (July 2016) Authors: Vogiatzi, F.; Brandt, D.T.; Fuchs, J.; Grikscheit, K.; Timofeev, O.; Nist, A.; Mernberger, M.; Grosse, R.; Stiewe, T. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗